Ping An Biomedical Co., Ltd. (PASW) — Institutional Holders, Q2 2026
4 institutional investment managers reported a PASW position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $49.4K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PASW in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSNew · +114,177 sh+$19.0K
- Virtu FinancialNew · +37,020 sh+$6.1K
Biggest sellers
- JANE STREET GROUPSold out · -52,518 sh-$8.7K
- TWO SIGMA SECURITIESTrimmed · -20,147 sh-$3.3K
- UBS Group AGSold out · -16,239 sh-$2.7K
- XTX Topco LtdTrimmed · -1,869 sh-$310.00
PASW 13F holders ranked 1–4 of 4
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | XTX Topco Ltd#1 · 134,558 sh | 134,558 | $22.3K | <0.01% | -1.4% |
| 2 | CITADEL ADVISORS#2 · 114,177 sh | 114,177 | $19.0K | 0.00% | New |
| 3 | Virtu Financial#3 · 37,020 sh | 37,020 | $6.0K | <0.01% | New |
| 4 | TWO SIGMA SECURITIES#4 · 13,076 sh | 13,076 | $2.1K | <0.01% | -60.6% |
Funds that sold out of PASW in Q2 2026 (2)
Held PASW at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| JANE STREET GROUP52,518 sh | 52,518 | $6.9K |
| UBS Group AG16,239 sh | 16,239 | $2.1K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.